Skip to content
Rheumatology Letter
  • Blog
  • About Us
  • Annals of Rheumatic Diseases
  • Current Opinion in Rheumatology
  • European Review | Rheumatology
  • Google News
  • Helio.com
  • JCR
  • Medpage
  • Medscape
  • Nature Reviews Rheumatology
  • NEJM
  • News-Medical.net | Rheumatology
  • Newsletters
  • PubMed
  • Rheumatology
  • Rheumatology Network Articles
  • RheumNow
  • Scandinavian Journal of Rheumatology
  • Science Direct
  • The Journal of Rheumatology
  • The Lancet
  • The Rheumatologist
  • Wiley
  • Blog
  • About Us
  • Annals of Rheumatic Diseases
  • Current Opinion in Rheumatology
  • European Review | Rheumatology
  • Google News
  • Helio.com
  • JCR
  • Medpage
  • Medscape
  • Nature Reviews Rheumatology
  • NEJM
  • News-Medical.net | Rheumatology
  • Newsletters
  • PubMed
  • Rheumatology
  • Rheumatology Network Articles
  • RheumNow
  • Scandinavian Journal of Rheumatology
  • Science Direct
  • The Journal of Rheumatology
  • The Lancet
  • The Rheumatologist
  • Wiley
logo
NEJM

Case 16-2025: A 34-Year-Old Man with a Nasopharyngeal Mass

  • by admin
  • June 11, 2025
A 34-year-old man was admitted to the hospital because of left ear pain with hearing loss and… Read More
Rheumatology

Update on streptococcal-associated rheumatic disease

  • by admin
  • June 3, 2025
Purpose of review This review provides a comprehensive perspective on poststreptococcal rheumatic manifestations in pediatric patients by… Read More
JCR

Evaluation of Factors Associated With Uveitis Onset Timing in Oligoarticular Juvenile Idiopathic Arthritis

  • by admin
  • June 1, 2025
Objective To evaluate the timing of uveitis onset in patients with oligoarticular juvenile idiopathic arthritis (oJIA) and… Read More
NEJM

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

  • by admin
  • May 28, 2025
In this randomized, placebo-controlled trial involving patients with giant-cell arteritis, the oral Janus kinase inhibitor upadacitinib (15… Read More
The Lancet

[Comment] One step closer to predicting autoimmune congenital heart block?

  • by admin
  • May 21, 2025
Autoimmune congenital heart block occurs in around 1–2% of anti-Sjögren’s syndrome-related antigen A (SSA)/Ro antibody-positive pregnancies.1 Despite… Read More
Rheumatology

Evolution of the axial spondyloarthritis disease activity score and uptake in clinical practice

  • by admin
  • May 20, 2025
Purpose of review This review outlines the development of the axial spondyloarthritis disease activity score (ASDAS) as… Read More
Rheumatology

Pathogenesis of juvenile idiopathic arthritis

  • by admin
  • May 4, 2025
Purpose of review To provide an overview of the most recent updates in the pathogenesis of juvenile… Read More
JCR

Interpretable Machine Learning for Predicting Anterior Uveitis in Axial Spondyloarthritis

  • by admin
  • April 24, 2025
Background Axial spondyloarthritis (axSpA) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, with… Read More
JCR

Moving the ACR’s Reproductive Health Guidelines Into Practice: A Quantitative and Qualitative Assessment of a Novel Reproductive Rheumatology ECHO

  • by admin
  • April 22, 2025
Background Project ECHO (Extension for Community Healthcare Outcomes) links experts with community providers through video teleconferences that… Read More
JCR

Comparative Efficacy and Safety of Different Regimens of Current JAK Inhibitors in Psoriatic Arthritis: A Network Meta-analysis

  • by admin
  • April 3, 2025
Background Janus kinase (JAK) inhibitors have been approved for treating psoriatic arthritis (PsA); however, the comparative efficacy… Read More
1 … 154 155 156 157 158

NewsBe Made by Couponvario | Powered by WordPress